Table I.
Antigena | Rv numberb | Restrictionc | Epitoped | Sequencee | Frequencyf | Ref |
---|---|---|---|---|---|---|
CFP10 | Rv3874 | a) HLA-B14 | a) CFP1085–94 | a) RADEEQQQAL | a) 1/2,100h; LTBIk | (22) |
b) HLA-B44 | b) CFP102–11 | b) AEMKTDAATL | b) 1/700h; LTBI | |||
CFP10 | Rv3874 | a) HLA-A*02 | a) CFP1076–85 | a) IRQAGVQYSR | ND | (147) |
b) HLA-B*35 | b) CFP1071–79 | b) EISTNIRQA | ||||
ESAT6 | Rv3875 | a) HLA-A2 | a) ESAT682–90 | a) AMASTEGNV | a) 1/50,000h; TB | (19) |
b) HLA-B52 | b) ESAT669–76 | b) LQNLARTI | b) 1/23,000h; TB | |||
ESAT6 | Rv3875 | HLA-A68.02 | ESAT621–29 | NVTSIHSLL | 1/2,500h; LTBI | (148) |
Ag85A | Rv3804c | HLA-A2 | a) Ag85A48–56 | a) GLPVEYLQV | a) 1/3,500g,i; BCG | (108) |
b) Ag85A242–250 | a) KLIANNTRV | b) 1/3,500g,i; BCG | ||||
Ag85B | Rv1886c | HLA-A2 | a) Ag85B143–152 | a) FIYAGSLSAL | ND | (109) |
b) Ag85B126–135 | b) SMAGSSAMIL | |||||
c) Ag85B199–207 | c) KLVANNTRL | |||||
d) Ag85B158–166 | d) GMGPSLIGL | |||||
Ag85B | Rv1886c | HLA-A*0201 | Ag85B15–23 | LMIGTAAAV | ND | (196) |
Ag85C | Rv0129c | HLA-B*3501 | Ag85C204–212 | WPTIIGLAM | 1/13,700–22,222h; BCG | (110) |
Ag85ABC | HLA-B*35 | Ag85A110–118 | MPVGGQSSF | ND | (110) | |
19 kDa | Rv3763 | HLA-A*0201 | 19 kDa88–97 | VLTDGNPPEV | ND | (18) |
19 kDa | Rv3763 | HLA-A*0201 | 19 kDa88–97 | VLTDGNPPEV | 1/123–769g,i | (153) |
16 kDa | Rv2031c | HLA-A*0201 | a) 16-kDa21–29 | a) LFAAFPSFA | ~ 1/1000g,j; TB | (156) |
b) 16-kDa120–128 | b) GILTVSVA | |||||
SodA | Rv3846 | HLA-A2 | SodA160–168 | DMWEHAFYL | ND | (227) |
AlaDH | Rv0512 | HLA-A2 | AlaDH160–169 | VLMGGVPGVE | ND | (227) |
GlnS | Rv2220 | HLA-A2 | GlnS308–316 | GLLHHAPSL | ND | (227) |
Mtb39 | Rv1196 | HLA-B44 | a) Mtb39144–153 | a) MWAQDAAAMF | ND | (116) |
b) Mtb39346–355 | b) AAERGPGQML | |||||
ThyA | Rv2764c | HLA-A*0201 | ThyA30–38 | RLPLVLPAV | ND | (196) |
PstA1 | Rv0930 | HLA-A*0201 | PstA175–83 | SLYFGGICV | ND | (196) |
Hbha | Rv0475 | ND | ND | ND | ND | (182) |
Common name for antigen.
The Rv designation for the mycobacterial protein.
The restricting MHC protein and allele, if known.
The location of the epitope within protein sequence.
The amino acid sequence of the epitope.
The frequency of antigen-specific T cells in PBMC unless otherwise stated.
The frequency of antigen-specific T cells among CD8+ T cells.
Determined using an Elispot assay.
Determined by flow cytometric analysis using peptide-loaded class I MHC-tetramers.
Determined by flow cytometric analysis using intracellular cytokine staining.
Infection status of subjects: LTBI, latent tuberculosis infection; TB, active tuberculosis; BCG, BCG vaccinated.
ND, not determined